Video

Enfortumab Vedotin (EV) Monotherapy and Pembrolizumab (P) Combination Treatments in Urothelial Cancer

Arlene Siefker-Radtke, MD, opens a discussion recapping the ESMO 2022 conference surrounding advanced and metastatic urothelial cancer.

Related Videos
Dr Gerard Criner
Dr Margrit Wiesendanger
4 experts are featured in this series.
4 experts are featured in this series.
2 experts in this video
2 experts in this video
Christine Funke, MD
5 experts are featured in this series
5 experts are featured in this series
1 expert in this video
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo